Luigi Naldi
Luigi Naldi publishes mostly in Immunology, Dermatology and Economics and Econometrics, on topics such as Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases and Pharmacovigilance and Adverse Drug Reactions.
- World rank
- #2,826,694 of 7,710,434 ranked researchers
- Rank in Italy
- #95,383 of 242,206
- Works
- 25
- Citations
- 971
- Citations per work
- 38.8
What does Luigi Naldi research?
Luigi Naldi's work is mostly in Medicine (20%), Immunology and Microbiology (16%), Economics, Econometrics and Finance (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1038.1%
- Health Sciences520.0%
- Medicine520.0%
- Social Sciences518.2%
- Life Sciences416.4%
- Physical Sciences27.3%
- Mathematics27.3%
- 1Immunology16% of their works
- 2Dermatology13% of their works
- 3Economics and Econometrics13% of their works
- 4Infectious Diseases7% of their works
- 5Statistics and Probability7% of their works
- 6Clinical Psychology6% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Pharmacovigilance and Adverse Drug Reactions
- COVID-19 Clinical Research Studies
- Diverse Scientific and Economic Studies
- Health Systems, Economic Evaluations, Quality of Life
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
Which keywords describe Luigi Naldi's research?
The keywords of their largest research topics: IL-17, TH17 Cells, Economic Evaluation, Filaggrin, Skin Microbiome, Adverse Drug Reactions, Clinical Characteristics and Cost-effectiveness Analysis.
- False Discovery Rate
- Adaptive Designs
- Quality of Life
- Monetary Policy
- Cost-effectiveness Analysis
- Adverse Drug Reactions
- Filaggrin
- TH17 Cells
- IL-17
- Economic Evaluation
- Skin Microbiome
- Clinical Characteristics
- Financial Analysis
- Pharmacovigilance
- SARS-CoV-2
- Causal Inference
- Propensity Score
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- IL-1791 topic
- TH17 Cells91 topic
- Economic Evaluation62 topics
- Filaggrin41 topic
- Skin Microbiome41 topic
- Adverse Drug Reactions31 topic
- Clinical Characteristics31 topic
- Cost-effectiveness Analysis31 topic
- Financial Analysis31 topic
- Monetary Policy31 topic
- Pharmacovigilance31 topic
- Quality of Life31 topic
- SARS-CoV-231 topic
- Adaptive Designs21 topic
- Causal Inference21 topic
- False Discovery Rate21 topic
- Propensity Score21 topic
Where does Luigi Naldi work?
Luigi Naldi's main affiliation in the publication record is Centro Studi GISED, Italy.
How many publications and citations does Luigi Naldi have?
OpenAlex counts 25 works and 971 citations for Luigi Naldi, an h-index of 5, ranking #2,826,694 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Luigi Naldi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luigi Naldi. Posts are plain text and can be reported.